SandboxAB: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nitrofurantoin]] 100 mg | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nitrofurantoin]] 100 mg po q12h×5 days'''''<br>OR<br>▸ '''''[[TMP-SMX]] 1 DS tab po q12h×3 days'''''<br>OR<br>'''''▸[[Fosfomycin]] 3 gm single dose'''''<br>OR<br> ▸'''''[[Pivmecillinam ]] 400 mg bid×5 days ''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluoroquinolones]] for 3 days <br>[[Ofloxacin]] 200–400 mg po bid.<br>[[Ciprofloxacin]] 250 mg bid po or Cipro XR 500 mg q24h<br>[[Levofloxacin]] 250–750 mg po q24'''''<br>OR<br>'''''▸[[β-lactam]] agents for 3-7 days<br>[[Amoxicillin-clavulanate]] 500/125 mg po tid or 875/125 mg po bid <br>[[Cefdinir]] 300 mg po q12h or 600 mg po q24 <br>[[Cefaclor]] 250-500 mg po q8h<br>[[Cefpodoxime-proxetil]] 100-200 mg po q12h''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluoroquinolones]] for 3 days <br>[[Ofloxacin]] 200–400 mg po bid.<br>[[Ciprofloxacin]] 250 mg bid po or Cipro XR 500 mg q24h<br>[[Levofloxacin]] 250–750 mg po q24'''''<br>OR<br>'''''▸[[β-lactam]] agents for 3-7 days<br>[[Amoxicillin-clavulanate]] 500/125 mg po tid or 875/125 mg po bid <br>[[Cefdinir]] 300 mg po q12h or 600 mg po q24 <br>[[Cefaclor]] 250-500 mg po q8h<br>[[Cefpodoxime-proxetil]] 100-200 mg po q12h'''''<br>Others([[Cephalexin]]250-500 mg po q6h ) not studied well but effective. | ||
|- | |- | ||
|} | |} |
Revision as of 00:15, 16 January 2014
|